Transforming a Global Development & Product Supply Network for Delivering a Multi-Modal Portfolio – It’s More than Flexible Facilities

  • Re-designing your organization to leverage capabilities across modalities In agile ways
  • Designing technology platforms as you design products
  • Laying the foundation for change during a pandemic builds flexibility and resilience in employees, setting the course for new ways of working and breaking down silos
  • Strengthening a culture of inclusion and driving diversity in leadership ranks

—

Jens Vogel
SVP & Global Head of Biotech
Bayer Pharmaceuticals

Dr. Jens Vogel rejoined Bayer in March of 2020 as Global Head of Biotech for the Bayer Pharmaceuticals Product Supply organization. He has more than 20 years of professional and leadership experience in the area of biologics operations, development and technology management. From 2012 until 2020, he held positions of increasing responsibility at Boehringer Ingelheim (BI), including as President and CEO of BI Fremont Inc and member of BI’s Biopharma Executive Committee. Prior to his years at BI, Dr. Vogel was a member of the Biologics Development Leadership team at Bayer in Berkeley. Jens holds a PhD in Biotechnology from University of Braunschweig, Institute of Technology, Germany.

Leave a comment